These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12769689)

  • 21. Mechanism and its regulation of tumor-induced angiogenesis.
    Gupta MK; Qin RY
    World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in tumor angiogenesis.
    Kilarski WW; Bikfalvi A
    Curr Pharm Biotechnol; 2007 Feb; 8(1):3-9. PubMed ID: 17311548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.
    Kumar CC
    Curr Drug Targets; 2003 Feb; 4(2):123-31. PubMed ID: 12558065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of angiogenesis in tumor growth and metastasis.
    Folkman J
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular targeted therapies in oncology.
    Siemann DW; Horsman MR
    Cell Tissue Res; 2009 Jan; 335(1):241-8. PubMed ID: 18752004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.
    Rak JW; St Croix BD; Kerbel RS
    Anticancer Drugs; 1995 Feb; 6(1):3-18. PubMed ID: 7538829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ErbB targeted drugs and angiogenesis.
    Iivanainen E; Elenius K
    Curr Vasc Pharmacol; 2010 May; 8(3):421-31. PubMed ID: 19485914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor as a target for anticancer therapy.
    Ferrara N
    Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor vasculature: the Achilles' heel of cancer?
    Johannessen TC; Wagner M; Straume O; Bjerkvig R; Eikesdal HP
    Expert Opin Ther Targets; 2013 Jan; 17(1):7-20. PubMed ID: 23121690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid-mediated effects on angiogenesis in solid tumors.
    Martens B; Drebert Z
    J Steroid Biochem Mol Biol; 2019 Apr; 188():147-155. PubMed ID: 30654109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel targets for anti-angiogenesis of genistein on human cancer cells.
    Su SJ; Yeh TM; Chuang WJ; Ho CL; Chang KL; Cheng HL; Liu HS; Cheng HL; Hsu PY; Chow NH
    Biochem Pharmacol; 2005 Jan; 69(2):307-18. PubMed ID: 15627483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic application of anti-angiogenic nanomaterials in cancers.
    Mukherjee S; Patra CR
    Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineovascular therapy, a novel antiangiogenic approach.
    Shimizu K; Asai T; Oku N
    Expert Opin Ther Targets; 2005 Feb; 9(1):63-76. PubMed ID: 15757482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nano-targeting vascular remodeling in cancer: Recent developments and future directions.
    Giordo R; Wehbe Z; Paliogiannis P; Eid AH; Mangoni AA; Pintus G
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):784-804. PubMed ID: 35257860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic inhibition of angiogenesis.
    Zhang HT; Bicknell R
    Mol Biotechnol; 2003 Oct; 25(2):185-200. PubMed ID: 14526126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondria as targets in angiogenesis inhibition.
    Park D; Dilda PJ
    Mol Aspects Med; 2010 Feb; 31(1):113-31. PubMed ID: 19995570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.